BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 29146225)

  • 41. Monoclonal Gammopathy of Undetermined Significance.
    Gonsalves WI; Rajkumar SV
    Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention.
    Landgren O; Kyle RA; Rajkumar SV
    Clin Cancer Res; 2011 Mar; 17(6):1243-52. PubMed ID: 21411440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events.
    Landgren O
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):662-672. PubMed ID: 34889381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Nielsen T; Kristensen SR; Gregersen H; Teodorescu EM; Pedersen S
    Thromb Res; 2021 Jun; 202():108-118. PubMed ID: 33819778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
    Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
    Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
    Zhan F; Barlogie B; Arzoumanian V; Huang Y; Williams DR; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Zangari M; Dhodapkar M; Shaughnessy JD
    Blood; 2007 Feb; 109(4):1692-700. PubMed ID: 17023574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.
    Bianchi G; Kyle RA; Colby CL; Larson DR; Kumar S; Katzmann JA; Dispenzieri A; Therneau TM; Cerhan JR; Melton LJ; Rajkumar SV
    Blood; 2010 Sep; 116(12):2019-25; quiz 2197. PubMed ID: 20495076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma.
    Dezube BJ; Aboulafia DM; Pantanowitz L
    AIDS Read; 2004 Jul; 14(7):372-4, 377-9. PubMed ID: 15282866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
    Liang CA; Zhang L; Segal G; Dasgupta A; Nguyen AND; Wahed A
    Ann Clin Lab Sci; 2020 Jan; 50(1):151-152. PubMed ID: 32161026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal gammopathy of undetermined significance (MGUS).
    Kyle RA
    Baillieres Clin Haematol; 1995 Dec; 8(4):761-81. PubMed ID: 8845571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?
    Papachristou S; Popovic DS; Papanas N
    Adv Ther; 2022 Jun; 39(6):2283-2286. PubMed ID: 35344184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
    Emery A; Moore S; Crowe J; Murray J; Peacock O; Thompson D; Betts F; Rapps S; Ross L; Rothschild-Rodriguez D; Arana Echarri A; Davies R; Lewis R; Augustine DX; Whiteway A; Afzal Z; Heaney J; Drayson MT; Turner JE; Campbell JP
    BMC Cancer; 2024 Feb; 24(1):174. PubMed ID: 38317104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pure Red Cell Aplasia Associated with Monoclonal Gammopathy of Undetermined Significance and Literature Review.
    Gu H; Lee WI; Jeon Y; Kang SY; Kim MH; Park TS
    Clin Lab; 2017 Feb; 63(2):373-378. PubMed ID: 28182355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
    Xu A; Guo T; Zhang S; Luo H; Shen M; Ye Y; Ji L
    Hematology; 2024 Dec; 29(1):2352686. PubMed ID: 38819332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.